Potential benefit of biventricular pacing in patients with congestive heart failure and ventricular tachyarrhythmia

American Journal of Cardiology

Volumn 83, Issue 5 B, 1999, Pages

  Stellbrink, Christoph ^a   Auricchio, Angelo ^b   Diem, Björn ^a   Breithardt, Ole Alexander ^a   Kloss, Michael ^b   Schöndube, Friedrich A ^a   Klein, Helmut ^b   Messmer, Bruno J ^a   Hanrath, Peter ^a  

^a RWTH AACHEN UNIVERSITY   (Germany)

^b OTTO VON GUERICKE UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AMIODARONE; AMLODIPINE; ANTIARRHYTHMIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM ANTAGONIST; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT;

ADULT; AGED; CARDIOVERSION; CLINICAL TRIAL; CONFERENCE PAPER; CONGESTIVE HEART FAILURE; DEFIBRILLATION; ELECTROCARDIOGRAM; FEMALE; HEART ARRHYTHMIA; HEART FAILURE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART PACING; HEART VENTRICLE ARRHYTHMIA; HEART VENTRICLE PACING; HUMAN; IMPLANTATION; MAJOR CLINICAL STUDY; MALE; MORTALITY; MULTICENTER STUDY; PRIORITY JOURNAL; TREATMENT OUTCOME;

EID: 0033545586     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9149(98)01016-9     Document Type: Conference Paper

References (71)

1. Eriksson H. Heart failure a growing public health problem . J Intern Med. 237:1995;135-141.
2. Ho K.K.L., Pinsky J.L., Kannel W.B., Levy D. The epidemiology of heart failure the Framingham study . J Am Coll Cardiol. 22:(suppl A):1993;6A-13A.
3. Kannel W.B., Belanger A.J. Epidemiology of heart failure. Am Heart J. 121:1991;951-957.
4. Cowie M.R., Mosterd A., Wood D.A., Deckers J.W., Poole-Wilson P.A., Sutton G.C., Grobbee D.E. The epidemiology of heart failure. Eur Heart J. 18:1997;208-225.
5. O'Connell J.B., Bristow M.R. Economic impact of heart failure in the United States time for a different approach . J Heart Lung Transplant. 13:1993;S107-S112.
6. Auricchio A., Stellbrink C., Block M., Mortensen P. Clinical and objective improvements in severe congestive heart failure patients using univentricular or biventricular pacing preliminary results of a randomized prospective study . (Abstr.) J Am Coll Cardiol. 31(2:(suppl A):1998;):31A.
7. Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure. N Engl J Med. 325:1991;293-302.
8. Gradman A., Deedwania P., Cody R., Massie B., Pitt B., Goldstein S. Predictors of total mortality and sudden death in mild to moderate heart failure. J Am Coll Cardiol. 14:1989;564-570.
9. Wilson J.R., Schwartz J.S., Sutton M.S., Ferraro N., Horowitz L.N., Reichek N., Josephson M.E. Prognosis in heart failure relation to hemodynamic measurements and ventricular ectopic activity . J Am Coll Cardiol. 2:1983;403-410.
10. Kjekshus J. Arrhythmias and mortality in congestive heart failure. Am J Cardiol. 65:(suppl):1990;42I-48I.
11. Franciosa J.A., Wilen M., Ziesche S., Cohn J.N. Survival in men with severe chronic left ventricular failure due to either coronary heart disease or idiopathic dilated cardiomyopathy. Am J Cardiol. 51:1983;831-836.
12. Smith W.M. Epidemiology of congestive heart failure. Am J Cardiol. 55:(suppl A):1985;3A-8A.
13. Effects of enalapril on mortality in severe congestive heart failure results of the Cooperative North Scandinavian Enalapril Survival Study . N Engl J Med. 316:1987;1429-1435.
14. Uretsky B.F., Sheahan R.G. Primary prevention of sudden cardiac death in heart failure will the solution be shocking? J Am Coll Cardiol. 30:1997;1589-1597.
15. Nikolic G., Bishop R.L., Singh J.B. Sudden death recorded during Holter monitoring. Circulation. 66:1982;218-225.
16. Savage D.D., Castelli W.P., Anderson S.J., Kannel W.B. Sudden unexpected death during ambulatory electrocardiographic monitoring. Am J Med. 74:1983;148-152.
17. Lewis B.H., Antman E.M., Graboys T.B. Detailed analysis of 24 hour ambulatory electrocardiographic recordings during ventricular fibrillation or torsade des pointes. J Am Coll Cardiol. 2:1983;426-436.
18. Pratt C.M., Francis M.J., Luck J.C., Wyndham C.R., Miller R.R., Quinones M.A. Analysis of ambulatory electrocardiograms in 15 patients during spontaneous ventricular fibrillation. J Am Coll Cardiol. 2:1983;789-797.
19. Panidis I.P., Morganroth J. Sudden death in hospitalized patients. Cardiac rhythm disturbances detected by ambulatory electrocardiographic monitoring. J Am Coll Cardiol. 2:1983;798-805.
20. Milner P.G., Platia E.V., Reid P.R., Griffith L.S. Ambulatory electrocardiographic recordings at the time of fatal cardiac arrest. Am J Cardiol. 56:1985;588-592.
21. Bayes de Luna A., Coumel P., Leclercq J.F. Ambulatory sudden cardiac death mechanisms of production of fatal arrhythmia on the basis of data from 157 cases . Am Heart J. 117:1989;151-159.
22. Olshausen K.V., Witt T., Pop T., Treese N., Bethge K.P., Meyer J. Sudden cardiac death while wearing a Holter monitor. Am J Cardiol. 67:1991;381-386.
23. Luu M., Stevenson L.W., Brunken R.C., Drinkwater D.C., Schelbert H.R., Tillisch J.H. Diverse mechanisms of unexpected cardiac arrest in advanced heart failure. Circulation. 80:1989;1675-1680.
24. Birgersdotter-Green U., Rosenqvist M., Ryden L. Effect of congestive heart failure treatment on incidence and prognosis of ventricular tachyarrhythmias. J Cardiovasc Pharmacol. 17:(suppl 6):1991;S53-S58.
25. Bigger J.T., Flesiss J.L., Kleiger R., Miller J.P., Rolnitzky L.M. The relationships among ventricular arrhythmias, left ventricular dysfunction and mortality in the 2 years after myocardial infarction. Circulation. 69:1984;250-258.
26. Hofmann T., Meinertz T., Kasper W., Geibel A., Zehender M., Hohnloser S., Stienen U., Treese N., Just H. Mode of death in idiopathic dilated cardiomyopathy a multivariate analyis of prognostic determinants . Am Heart J. 116:1988;1455-1461.
27. Doval H.C., Nul D.R., Grancelli H.O., Varini S.D., Soifer S., Corrado G., Dubner S., Scapin O., Perrone S.V. Nonsustained ventricular tachycardia in severe heart failure. Independent marker of increased mortality due to sudden death. Circulation. 94:1996;3198-3203.
28. Uretsky B.F., Young J.B., Shahidi E., Yellen L.G., Harrison M.C., Jolly K. Randomized study assessing the effect of digoxin withdrawal in patients with mild to moderate chronic congestive heart failure results from the PROVED trial . J Am Coll Cardiol. 22:1993;955-962.
29. Packer M., Gheorgiade M., Young J.B., Constantini P.J., Adams K.F., Cody R.J., Smith L.K., Van Voorhees L., Gourley L.A., Jolly M.K. Withdrawal of digoxin from patients with chronic heart failure treated with angiotensin-converting-enzyme inhibitors. N Engl J Med. 329:1993;1-7.
30. The effect of digoxin on mortality and morbidity in patients with heart failure. N Engl J Med. 336:1997;525-533.
31. Patterson J.H., Adams K.F. Jr, Applefield M.M., Corder C.N., Masse B.R. Oral torasemide in patients with chronic congestive heart failure effects on body weight, edema and electrolyte excretion . Pharmacotherapy. 14:1994;514-521.
32. Pfeffer M.A., Braunwald E., Moye L.A., Basta L., Brown E.J. Jr, Cuddy T.E., Davis B.R., Geltman E.M., Goldman S., Flaker G.C. Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction - results of the survival and ventricular enlargement study. N Engl J Med. 327:1992;669-677.
33. Effect of ramipril on mortality and morbidity of survivors of acute myocardial infarction with clinical evidence of heart failure. Lancet. 2:1993;821-827.
34. Kober L., Torp Pedersen C., Carlsen J.E., Bagger H., Eliasen P., Lyngborg K., Videbaek J., Cole D.S., Auclert L., Pauly N.C. A clinical trial of the angiotensin-converting enzyme inhibitor trandolapril in patients with severe left ventricular dysfunction after myocardial infarction. N Engl J Med. 333:1995;1670-1676.
35. Ambrosioni E., Borghi C., Magnani B. The effect of the angiotensin-converting enzyme inhibitor zofenopril on mortality and morbidity after prior myocardial infarction. N Engl J Med. 332:1995;80-85.
36. Echt D.S., Liebson P.R., Mitchell L.B., Peters R.W., Obias-Manno D., Barker A.H., Arensberg D., Baker A., Friedman L., Greene H.L. Mortality and morbidity in patients receiving encainide, flecainide, or placebo the Cardiac Arrhythmia Suppression Trial . N Engl J Med. 324:1991;781-788.
37. Flaker G.C., Blackshear J.L., McBride R., Kronmal R.A., Halperin J.L., Hart R.G. Antiarrhythmic drug therapy and cardiac mortality in atrial fibrillation. J Am Coll Cardiol. 20:1992;527-532.
38. Timolol-induced reduction in mortality and reinfarction in patients surviving acute myocardial infarction. N Engl J Med. 304:1981;801-807.
39. A randomized trial of propanolol in patients with acute myocardial infarction: I. Mortality results. JAMA. 1981;1707-1714.
40. Gundersen T. Influence of heart size on mortality and reinfarction in patients treated with timolol after myocardial infarction. Br Heart J. 50:1983;135-139.
41. Gottlieb S.S., McCarter R.J., Vogel R.A. Effect of beta-blockade on mortality among high-risk and low-risk patients after myocardial infarction. N Engl J Med. 339:1998;489-497.
42. Packer M., Bristow M.R., Cohn J.N., Colucci W.S., Fowler M.B., Gilbert E.M., Shusterman N.H. The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. N Engl J Med. 334:1996;1349-1355.
43. Julian D.G., Camm A.J., Frangin G., Janse M.J., Munoz A.A., Schwartz P.J., Simon P. Randomised trial of effect of amiodarone on mortality in patients with left-ventricular dysfunction after recent myocardial infarction EMIAT . Lancet. 349:1997;667-674.
44. Cairns J.A., Connolly S.J., Roberts R., Gent M. Randomised trial of outcome after myocardial infarction in patients with frequent or repetitive ventricular premature depolarisations CAMIAT . Lancet. 349:1997;675-682.
45. Doval H.C., Nul D.R., Grancelli H.O., Perrone S.V., Bortman G.R., Curiel R. Randomised trial of low-dose amiodarone in severe congestive heart failure. Lancet. 344:1994;493-498.
46. Singh S.N., Fletcher R.D., Fisher S.G., Singh B.N., Lewis H.D., Deedwania P.C., Massie B.M., Colling C., Lazzeri D. Amiodarone in patients with congestive heart failure and asymptomatic ventricular arrhythmia. N Engl J Med. 333:1995;77-82.
47. Effect of prophylactic amiodarone on mortality after acute myocardial infarction and in congestive heart failure: meta-analysis of individual data from 6500 patients in randomised trials . Lancet. 350:1997;1417-1424.
48. Teo K.K., Yusuf S., Furberg C.D. Effects of prophylactic antiarrhythmic drug therapy in acute myocardial infarction. JAMA. 270:1993;1589-1595.
49. Packer M., O'Connor C.M., Ghali J.K., Pressler M.L., Carson P.E., Belkin R.N., Miller A.B., Neuberg G.W., Frid D., Wertheimer J.H., Cropp A.B., DeMets D.L. Effect of amlodipine on morbidity and mortality in severe chronic heart failure. N Engl J Med. 335:1996;1107-1114.
50. Figulla H.R., Gietzen F., Zeymer U., Raiber M., Hegselmann J., Soballa R., Hilgers R. Diltiazem improves cardiac function and exercise capacity in patients with idiopathic dilated cardiomyopathy results of the diltiazem in dilated cardiomyopathy trial . Circulation. 94:1996;346-352.
51. A comparison of antiarrhythmic-drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias. N Engl J Med. 337:1997;1576-1583.
52. Connolly S.J., Gent M., Roberts R.S., Dorian P., Green M.S., Klein G.J., Mitchell L.B., Sheldon R.S., Roy D. Canadian Implantable Defibrillator Study (CIDS) study design and organization . Am J Cardiol. 72:(suppl):1993;103F-108F.
53. Siebels J., Kuck K.H. Implantable cardioverter defibrillator compared with antiarrhythmic drug treatment in cardiac arrest survivors (the Cardiac Arrest Study Hamburg). Am Heart J. 127:1994;1139-1144.
54. Moss A.J., Hall J., Cannom D.S., Daubert J.P., Higgins S.L., Klein H., Levine J.H., Saksena S., Waldo A.L., Wilber D., Brown M.W., Heo M. Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia. N Engl J Med. 335:1996;1933-1940.
55. Kim S.G., Maloney J.D., Pinski S.L., Choue C.W., Ferrick K.J., Roth J.A., Gross J., Brodman R., Furman S., Fisher J.D. Influence of left ventricular function on survival and mode of death after implantable defibrillator therapy (Cleveland Clinic Foundation and Montefiore Medical Center experience). Am J Cardiol. 72:1993;1263-1267.
56. Sweeney M.O., Ruskin J.N., Garan H., McGovern B.A., Guy M.L., Torchiana D.F., Vlahakes G.J., Newell J.B., Semigran M.J., Dee W. Influence of the implantable cardioverter/defibrillator on sudden death and total mortality in patients evaluated for cardiac transplantation. Circulation. 92:1995;3273-3281.
57. Kim S.G. Implantable defibrillator therapy: does it really prolong life? How can we prove it? Am J Cardiol. 71:1993;1213-1218.
58. Guarnieri T., Levine J.H., Griffith L.S.C., Veltri E.P. When sudden cardiac death is not so sudden lessons learned from the automatic implantable defibrillator . Am Heart J. 115:1988;205-207.
59. Hochleitner M., Hortnagl H., Ng C., Hortnagl H., Gschnitzer F., Zechmann W. Usefulness of physiologic dual-chamber pacing in drug resistant idiopathic dilated cardiomyopathy. Am J Cardiol. 66:1990;198-202.
60. Auricchio A., Sommariva L., Salo R.W., Scafuri A., Chiariello L. Improvement of cardiac function in patients with severe congestive heart failure and coronary artery disease with shortened AV delay. Pacing Clin Electrophysiol. 16:1993;2034-2043.
61. Brecker S.J.D., Xiao H.B., Sparrow J., Gibson D.G. Effects of dual-chamber pacing with short atrioventricular delay in dilated cardiomyopathy. Lancet. 340:1992;1308-1312.
62. Nishimura R.A., Hayes D.L., Holmes D.R. Jr, Tajik A.J. Mechanism of hemodynamic improvement by dual-chamber pacing for severe left ventricular dysfunction an acute Doppler and catheterization hemodynamic study . J Am Coll Cardiol. 25:1995;281-288.
63. Linde C., Gadler F., Edner M., Nordlander R., Rosenqvist M., Ryden L. Results of atrioventricular synchronous pacing with optimized delay in patients with severe congestive heart failure. Am J Cardiol. 75:1995;919-923.
64. Gold M.R., Feliciano Z., Gottlieb S.S., Fisher M.L. Dual-chamber pacing with a short atrioventricular delay in congestive heart failure a randomized study . J Am Coll Cardiol. 26:1995;967-973.
65. Shinbane J.S., Chu E., DeMarco T., Sobol Y., Fitzpatrick A.P., Lau D.M., Klinski C., Schiller N.B., Griffin J.C., Chatterjee K. Evaluation of acute dual-chamber pacing with a range of atrioventricular delays on cardiac performance in refractory heart failure. J Am Coll Cardiol. 30:1997;1295-1300.
66. Kerwin W.F., Botvinick E.H., O'Connell M.S., Merrick S.H., DeMarco T., Chatterjee K., Saxon L.A. Biventricular pacing in dilated cardiomyopathy acute improvements in biventricular ejection fraction correspond with measures of improved RV/LV synchrony . (Abstr.) PACE Pacing Clin Electrophysiol. 21:1998;189.
67. Blanc J.J., Etienne Y., Gilard M., Mansourati J., Munier S., Boschat J., Benditt D.G., Lurie K.G. Evaluation of different ventricular pacing sites in patients with severe heart failure results of an acute hemodynamic study . Circulation. 96:1997;3273-3277.
68. Cazeau S., Ritter P., Lazarus A., Gras D., Backdach H., Mundler O., Mugica J. Multisite pacing for end-stage heart failure early experience . PACE Pacing Clin Electrophysiol. 19:1996;1748-1757.
69. Saxon L.A., DeMarco T., Chatterjee K., Boehmer J. The magnitude of sympathoneural activation in advanced heart failure is altered with chronic biventricular pacing. (Abstr.) PACE Pacing Clin Electrophysiol. 21:1998;499.
70. Daubert C., Linde C., Cazeau S., Sutton R., Kappenberger L., Bailleul C. Protocol design of the MUSTIC (Multisite Stimulation in Cardiomyopathy) study. (Abstr.) Arch Mal Coeur Vaiss. 91:1998;154.
71. Lamp B., Hammel D., Kerber S., Deng M., Breithardt G., Block M. Multisite pacing in severe heart failure - how many patients are eligible? (Abstr.) PACE Pacing Clin Electrophysiol. 21:1998;736.